{
    "2018-10-22": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Undervalued Companies With Predictable Businesses",
                "features": {
                    "keywords": [
                        "undervalued",
                        "predictable",
                        "companies"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "How Novartisâ€™s Innovative Medicines Business Performed in Q3",
                "features": {
                    "keywords": [
                        "Novartis",
                        "innovative medicines",
                        "Q3 performance"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}